Wei-Peng Wang - Concepedia

Author

Wei-Peng Wang

University of California, Davis

Also Known As

Wei-Peng Wang

Publications

756

Citations

H-Index

Concepts

All Affiliations

University of California, Davis Zhejiang University Roswell Park Comprehensive Cancer Center Sun Yat-sen University Zhongnan Hospital of Wuhan University

About

Wei-Peng Wang is an author at University of California, Davis specializing in cancer research, medicine, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	478
2	Engineering	1	1	80
3	Natural Sciences	1	1	80
4	Biomolecular Engineering	1	1	80
5	Microbiology	1	1	80

Wei-Peng Wang

Publications

694

Citations

H-Index

Page 1

	Year	Citations
Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies a susceptibility locus at PLCE1 Lidong Wang, Fuyou Zhou, Xue-Min Li, Nature Genetics Genome-wide Association StudyChinese SubjectsEsophageal CancerGeneticsGenetic Epidemiology	2010	416
A general approach to high-yield biosynthesis of chimeric RNAs bearing various types of functional small RNAs for broad applications Qiuxia Chen, Wei-Peng Wang, Su Zeng, Nucleic Acids Research High-yield BiosynthesisEngineeringMolecular BiologyGeneral ApproachBiosynthesis	2015	80
Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth Yong Zhao, Mei‐Juan Tu, Yi-Feng Yu, Biochemical Pharmacology OncologyNovel TherapyMedicinePathologyCombination Therapy	2015	62
Chimeric MicroRNA-1291 Biosynthesized Efficiently in Escherichia coli Is Effective to Reduce Target Gene Expression in Human Carcinoma Cells and Improve Chemosensitivity Mei-Mei Li, Balasubrahmanyam Addepalli, Mei‐Juan Tu, Drug Metabolism and Disposition	2015	58
Genetically engineered pre-microRNA-34a prodrug suppresses orthotopic osteosarcoma xenograft tumor growth via the induction of apoptosis and cell cycle arrest Yong Zhao, Mei‐Juan Tu, Wei-Peng Wang, Scientific Reports	2016	43
Rapid Production of Novel Pre-MicroRNA Agent hsa-mir-27b in Escherichia coli Using Recombinant RNA Technology for Functional Studies in Mammalian Cells Mei-Mei Li, Wei-Peng Wang, Wen-Juan Wu, Drug Metabolism and Disposition	2014	35

Page 1